Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma

NCT02528214 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02528214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02528214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 15, 2015
Completion date
November 13, 2017
Enrollment
210 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

asthma